223 related articles for article (PubMed ID: 20049704)
41. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.
Evans AJ; Russell RC; Roche O; Burry TN; Fish JE; Chow VW; Kim WY; Saravanan A; Maynard MA; Gervais ML; Sufan RI; Roberts AM; Wilson LA; Betten M; Vandewalle C; Berx G; Marsden PA; Irwin MS; Teh BT; Jewett MA; Ohh M
Mol Cell Biol; 2007 Jan; 27(1):157-69. PubMed ID: 17060462
[TBL] [Abstract][Full Text] [Related]
42. Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor.
Wacker I; Sachs M; Knaup K; Wiesener M; Weiske J; Huber O; Akçetin Z; Behrens J
Mol Cell Biol; 2009 Apr; 29(7):1707-18. PubMed ID: 19158274
[TBL] [Abstract][Full Text] [Related]
43. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
Bonicalzi ME; Groulx I; de Paulsen N ; Lee S
J Biol Chem; 2001 Jan; 276(2):1407-16. PubMed ID: 11024059
[TBL] [Abstract][Full Text] [Related]
44. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
45. The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells.
Razorenova OV; Castellini L; Colavitti R; Edgington LE; Nicolau M; Huang X; Bedogni B; Mills EM; Bogyo M; Giaccia AJ
Mol Cell Biol; 2014 Feb; 34(4):739-51. PubMed ID: 24344197
[TBL] [Abstract][Full Text] [Related]
46. von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.
Hong S; Yum S; Ha NC; Jung Y
Anal Biochem; 2010 Dec; 407(2):220-5. PubMed ID: 20705044
[TBL] [Abstract][Full Text] [Related]
47. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
48. Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis.
Serrano-Oviedo L; Giménez-Bachs JM; Nam-Cha SY; Cimas FJ; García-Cano J; Sánchez-Prieto R; Salinas-Sánchez AS
Urol Oncol; 2017 Mar; 35(3):114.e15-114.e22. PubMed ID: 27836247
[TBL] [Abstract][Full Text] [Related]
49. Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway.
Chung J; Roberts AM; Chow J; Coady-Osberg N; Ohh M
Oncogene; 2006 May; 25(21):3079-83. PubMed ID: 16407835
[TBL] [Abstract][Full Text] [Related]
50. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
52. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
53. The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1.
Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
Arch Biochem Biophys; 2012 Feb; 518(2):103-10. PubMed ID: 22234250
[TBL] [Abstract][Full Text] [Related]
54. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
55. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
[TBL] [Abstract][Full Text] [Related]
56. HIF activation by pH-dependent nucleolar sequestration of VHL.
Mekhail K; Gunaratnam L; Bonicalzi ME; Lee S
Nat Cell Biol; 2004 Jul; 6(7):642-7. PubMed ID: 15181450
[TBL] [Abstract][Full Text] [Related]
57. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
Hughson MD; He Z; Liu S; Coleman J; Shingleton WB
Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449
[TBL] [Abstract][Full Text] [Related]
58. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
59. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
60. Consequences of VHL Loss on Global DNA Methylome.
Robinson CM; Lefebvre F; Poon BP; Bousard A; Fan X; Lathrop M; Tost J; Kim WY; Riazalhosseini Y; Ohh M
Sci Rep; 2018 Feb; 8(1):3313. PubMed ID: 29463811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]